| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000002262 |
| Receipt No. | R000002768 |
| Official scientific title of the study | Comprehensive analyses of viral factors in hepatitis C patients receiving interferon-related therapy. |
| Date of disclosure of the study information | 2013/03/31 |
| Last modified on | 2019/02/04 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Comprehensive analyses of viral factors in hepatitis C patients receiving interferon-related therapy. | |
| Title of the study (Brief title) | Comprehensive analyses of viral factors in hepatitis C patients | |
| Region |
|
|
| Condition | ||
| Condition | hepatitis C | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To clarify the viral factors that determine the efficacy of anti-viral therapy on patients with chronic hepatitis C |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Association between the efficacy of the therapy and the mutations of hepatitis C viral sequences |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with chronic hepatitis caused by hepatitis C virus infeciton | |||
| Key exclusion criteria | Patients without the indication of anti-viral therapy | |||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroyuki Marusawa |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | Dep.Gastroenterology and Hepatology |
| Address | Shogoin-Kawaracho 54, Sakyo-ku, Kyoto |
| TEL | 075-751-4319 |
| maru@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Hiroyuki Marusawa |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | Dep.Gastroenterology and Hepatology |
| Address | Shogoin-Kawaracho 54, Sakyo-ku, Kyoto |
| TEL | 075-751-4319 |
| Homepage URL | |
| maru@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Graduate School of Medicine, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | AMED |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | We examine whether the certain viral mutations of hepatitis C genomes are associated with the efficacy of the anti-viral therapy in patients with chronic hepatitis C. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002768 |